Navigation Links
Drugs Used to Fight Cholesterol Could Also Help in Mesothelioma Treatment, Baron and Budd Reports
Date:8/14/2014

DALLAS (PRWEB) August 15, 2014

A team of Korean researchers has found that a drug normally used to lower cholesterol could also help a commonly used chemotherapy medication kill malignant mesothelioma cells, the mesothelioma law firm of Baron and Budd reports. The results of the research team’s work was published in the latest issue of the International Journal of Oncology. (http://www.ncbi.nlm.nih.gov/pubmed/25096993)

Cholesterol-lowering drugs, or statins, such as simvastatin have been shown to cause apoptosis, or the killing of certain types of mesothelioma cells. When they paired simvastatin with the chemotherapy drug pemetrexed, the researchers found the combination was more effective than the use of either drug on its own. According to the study, the combination increased the production of ROS, or reactive oxygen species. ROS is an indicator of cellular stress wherein the mitochondria – the portion of a cell that produces energy – is weakened.

The research team found that the simvastatin and pemetrexed combination activated a molecule called Bim that accelerates the process of apoptosis. If the findings of the team are confirmed by further laboratory study, the combination will be tested in mesothelioma patients.
The most widely accepted chemotherapy treatment, for malignant pleural mesothelioma patients is currently a combination of pemetrexed with cisplatin. However, that has only proven to be moderately successful. Typically, mesothelioma patients undergo different types of treatments, including chemotherapy, surgery and drug therapy.

“We applaud and appreciate the incredibly hard work these and other medical professionals are doing in order to treat this horrible disease,” said Russell Budd, co-founder and managing director of the mesothelioma law firm of Baron and Budd.

Mesothelioma can occur after the inhalation or ingestion of asbestos fibers. If you or someone close to you developed the disease after being exposed to asbestos, you may be able to pursue legal action. Please contact the national mesothelioma law firm of Baron and Budd to learn more. Call us at 1-866-855-1229 or visit our website at http://www.fightmesothelioma.com to learn more.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12094588.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pharmacy Robots Linked to Bacterial Contamination of Drugs
2. Penn study cautions use of drugs to block niacin flush
3. Urinary Incontinence Drugs May Be More Trouble Than Theyre Worth
4. Discovery could help to develop drugs for organ transplant and cancer patients
5. Not taking gastroprotective drugs prescribed with anti-inflammatory medicines
6. Live imaging shows response to cancer drugs can be boosted by altering tumor microenvironment
7. Weight-Loss Surgery Beat Drugs for Cutting Diabetes in Very Obese
8. Seniors Stop Taking Heart Drugs In Medicare Donut Hole
9. New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds
10. About 1 baby born each hour addicted to opiate drugs in U.S., U-M study shows
11. Blood pressure drugs linked with lower PTSD symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... For ... assistance management solution to the exhibit floor for the 2017 HIMSS Conference ... , From Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are expected ...
(Date:2/17/2017)... Seattle, WA (PRWEB) , ... February 17, 2017 ... ... health management organizations, has been named a finalist in the 8th Annual DecisionHealth ... impacting America's healthcare delivery system. Qualis Health’s work is recognized across multiple award ...
(Date:2/17/2017)... ... 2017 , ... Pharmica Consulting attended CHI's 8th Annual SCOPE ... trial planning and management. Pharmica discussed the importance of effective project management, data ... by Pharmica’s booth were able to demo its cloud-based Resource Management Tool, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Top neuroendocrine cancer doctors, nurses and specialists from ... February 21 - 23 in Beaver Creek, CO. It was announced today by Cindy ... year in Beaver Creek, hosting over 60 faculty members and addressing unmet needs of ...
(Date:2/16/2017)... ... 17, 2017 , ... For some cancer survivors, the memories ... Physician researchers at The Marcus Institute of Integrative Health at Thomas Jefferson ... reducing symptoms of traumatic stress in cancer patients and published their results ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 17, 2017  Noble Capital Markets announced today that ... (Nasdaq: EPIX ). The report was issued ... , PhD. ESSA Pharmaceuticals is a clinical ... cancer (CRPC). Its lead compound EPI-506, is a small ... of the androgen receptor, thereby has potential to overcome ...
(Date:2/16/2017)... Quest Diagnostics (NYSE: DGX ), ... announced that it has been named one of the ... The annual survey designated Quest Diagnostics as ... Pharmacy and Other Services" industry to attain Most Admired ... attain the designation. This is the second consecutive year ...
(Date:2/16/2017)... Feb. 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... company, today announced that executive management will participate in ... held February 22-23, 2017. Adrian Adams , Chief ... at 1:35 p.m. local time on Wednesday, February 22, ... for the event may be accessed from the Investors ...
Breaking Medicine Technology: